Cargando…
de Novo TINF2 C.845G>A: Pathogenic Variant in Patient with Dyskeratosis Congenita
Dyskeratosis congenita (DC) is a clinically and genetically heterogeneous, multisystem inherited syndrome with a very high risk for bone marrow failure (BMF) and cancer predisposition. The classical clinical form of DC is characterized by abnormal skin pigmentation, nail dystrophy, and oral leukopla...
Autores principales: | Kocheva, SA, Gjorgjievska, M, Martinova, K, Antevska-Trajkova, Z, Jovanovska, A, Plaseska-Karanfilska, D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sciendo
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524180/ https://www.ncbi.nlm.nih.gov/pubmed/36249522 http://dx.doi.org/10.2478/bjmg-2021-0027 |
Ejemplares similares
-
Autoimmune lymphoproliferative syndrome identified through reverse phenotyping
por: Kocheva, Svetlana, et al.
Publicado: (2022) -
Novel Mutation of the TINF2 Gene in a Patient with Dyskeratosis Congenita
por: Panichareon, Benjaporn, et al.
Publicado: (2015) -
Editing TINF2 as a potential therapeutic approach to restore telomere length in dyskeratosis congenita
por: Choo, Seunga, et al.
Publicado: (2022) -
Tissue-specific telomere shortening and degenerative changes in a patient with TINF2 mutation and dyskeratosis congenita
por: Roake, Caitlin M., et al.
Publicado: (2021) -
Novel TINF2 gene mutation in dyskeratosis congenita with extremely short telomeres: A case report
por: Picos-Cárdenas, Verónica Judith, et al.
Publicado: (2022)